ICHOR HOLDINGS LTD (ICHR) Stock Fundamental Analysis

NASDAQ:ICHR • KYG4740B1059

50.35 USD
+2.51 (+5.25%)
At close: Feb 20, 2026
50.86 USD
+0.51 (+1.01%)
After Hours: 2/20/2026, 8:00:01 PM
Fundamental Rating

3

Overall ICHR gets a fundamental rating of 3 out of 10. We evaluated ICHR against 113 industry peers in the Semiconductors & Semiconductor Equipment industry. The financial health of ICHR is average, but there are quite some concerns on its profitability. ICHR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year ICHR was profitable.
  • ICHR had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: ICHR reported negative net income in multiple years.
  • ICHR had a positive operating cash flow in each of the past 5 years.
ICHR Yearly Net Income VS EBIT VS OCF VS FCFICHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

  • ICHR has a Return On Assets of -5.60%. This is in the lower half of the industry: ICHR underperforms 67.26% of its industry peers.
  • With a Return On Equity value of -7.95%, ICHR is not doing good in the industry: 66.37% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -5.6%
ROE -7.95%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ICHR Yearly ROA, ROE, ROICICHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

1.3 Margins

  • ICHR's Gross Margin of 9.26% is on the low side compared to the rest of the industry. ICHR is outperformed by 86.73% of its industry peers.
  • ICHR's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ICHR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.6%
GM growth 5Y-8.76%
ICHR Yearly Profit, Operating, Gross MarginsICHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15

4

2. Health

2.1 Basic Checks

  • ICHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for ICHR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ICHR Yearly Shares OutstandingICHR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ICHR Yearly Total Debt VS Total AssetsICHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 4.96 indicates that ICHR is not in any danger for bankruptcy at the moment.
  • ICHR has a Altman-Z score of 4.96. This is comparable to the rest of the industry: ICHR outperforms 55.75% of its industry peers.
  • ICHR has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • ICHR has a Debt to Equity ratio (0.18) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z 4.96
ROIC/WACCN/A
WACC10.97%
ICHR Yearly LT Debt VS Equity VS FCFICHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 3.16 indicates that ICHR has no problem at all paying its short term obligations.
  • ICHR's Current ratio of 3.16 is in line compared to the rest of the industry. ICHR outperforms 55.75% of its industry peers.
  • A Quick Ratio of 1.38 indicates that ICHR should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.38, ICHR is doing worse than 78.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.16
Quick Ratio 1.38
ICHR Yearly Current Assets VS Current LiabilitesICHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 43.75% over the past year.
  • Measured over the past years, ICHR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -37.90% on average per year.
  • The Revenue has grown by 11.61% in the past year. This is quite good.
  • Measured over the past years, ICHR shows a small growth in Revenue. The Revenue has been growing by 0.72% on average per year.
EPS 1Y (TTM)43.75%
EPS 3Y-60.1%
EPS 5Y-37.9%
EPS Q2Q%-87.5%
Revenue 1Y (TTM)11.61%
Revenue growth 3Y-9.54%
Revenue growth 5Y0.72%
Sales Q2Q%-4.15%

3.2 Future

  • ICHR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 94.84% yearly.
  • ICHR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.14% yearly.
EPS Next Y249.08%
EPS Next 2Y165.13%
EPS Next 3Y100.96%
EPS Next 5Y94.84%
Revenue Next Year14.13%
Revenue Next 2Y12.88%
Revenue Next 3Y11.53%
Revenue Next 5Y13.14%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ICHR Yearly Revenue VS EstimatesICHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B
ICHR Yearly EPS VS EstimatesICHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 218.91, which means the current valuation is very expensive for ICHR.
  • ICHR's Price/Earnings ratio is in line with the industry average.
  • ICHR is valuated expensively when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 62.71, ICHR can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ICHR is on the same level as its industry peers.
  • ICHR's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 218.91
Fwd PE 62.71
ICHR Price Earnings VS Forward Price EarningsICHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ICHR Per share dataICHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ICHR's earnings are expected to grow with 100.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.88
PEG (5Y)N/A
EPS Next 2Y165.13%
EPS Next 3Y100.96%

0

5. Dividend

5.1 Amount

  • ICHR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ICHOR HOLDINGS LTD

NASDAQ:ICHR (2/20/2026, 8:00:01 PM)

After market: 50.86 +0.51 (+1.01%)

50.35

+2.51 (+5.25%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-09
Earnings (Next)05-04
Inst Owners98.06%
Inst Owner Change-1.42%
Ins Owners2.11%
Ins Owner Change19.13%
Market Cap1.73B
Revenue(TTM)947.65M
Net Income(TTM)-52.78M
Analysts75.38
Price Target30.75 (-38.93%)
Short Float %8.3%
Short Ratio2.92
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)37.67%
Min EPS beat(2)-42.12%
Max EPS beat(2)117.46%
EPS beat(4)1
Avg EPS beat(4)-14.74%
Min EPS beat(4)-79.27%
Max EPS beat(4)117.46%
EPS beat(8)3
Avg EPS beat(8)-563.34%
EPS beat(12)5
Avg EPS beat(12)-364.79%
EPS beat(16)7
Avg EPS beat(16)-272.7%
Revenue beat(2)0
Avg Revenue beat(2)-0.48%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)-0.23%
Revenue beat(4)1
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)0.45%
Revenue beat(8)3
Avg Revenue beat(8)-0.37%
Revenue beat(12)6
Avg Revenue beat(12)-0.22%
Revenue beat(16)8
Avg Revenue beat(16)-0.11%
PT rev (1m)26.47%
PT rev (3m)21.38%
EPS NQ rev (1m)2.48%
EPS NQ rev (3m)-284.49%
EPS NY rev (1m)0.85%
EPS NY rev (3m)-58.03%
Revenue NQ rev (1m)0.12%
Revenue NQ rev (3m)-0.78%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.98%
Valuation
Industry RankSector Rank
PE 218.91
Fwd PE 62.71
P/S 1.83
P/FCF N/A
P/OCF 57.92
P/B 2.61
P/tB 6.01
EV/EBITDA N/A
EPS(TTM)0.23
EY0.46%
EPS(NY)0.8
Fwd EY1.59%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.87
OCFY1.73%
SpS27.56
BVpS19.31
TBVpS8.38
PEG (NY)0.88
PEG (5Y)N/A
Graham Number10
Profitability
Industry RankSector Rank
ROA -5.6%
ROE -7.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.26%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.6%
GM growth 5Y-8.76%
F-Score3
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 107.95%
Cap/Sales 3.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.16
Quick Ratio 1.38
Altman-Z 4.96
F-Score3
WACC10.97%
ROIC/WACCN/A
Cap/Depr(3y)70.04%
Cap/Depr(5y)74.83%
Cap/Sales(3y)2.6%
Cap/Sales(5y)2.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.75%
EPS 3Y-60.1%
EPS 5Y-37.9%
EPS Q2Q%-87.5%
EPS Next Y249.08%
EPS Next 2Y165.13%
EPS Next 3Y100.96%
EPS Next 5Y94.84%
Revenue 1Y (TTM)11.61%
Revenue growth 3Y-9.54%
Revenue growth 5Y0.72%
Sales Q2Q%-4.15%
Revenue Next Year14.13%
Revenue Next 2Y12.88%
Revenue Next 3Y11.53%
Revenue Next 5Y13.14%
EBIT growth 1Y-414.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year552.33%
EBIT Next 3Y110.3%
EBIT Next 5Y99.45%
FCF growth 1Y-161.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.2%
OCF growth 3Y-1.69%
OCF growth 5Y-4.82%

ICHOR HOLDINGS LTD / ICHR FAQ

What is the ChartMill fundamental rating of ICHOR HOLDINGS LTD (ICHR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ICHR.


Can you provide the valuation status for ICHOR HOLDINGS LTD?

ChartMill assigns a valuation rating of 2 / 10 to ICHOR HOLDINGS LTD (ICHR). This can be considered as Overvalued.


How profitable is ICHOR HOLDINGS LTD (ICHR) stock?

ICHOR HOLDINGS LTD (ICHR) has a profitability rating of 2 / 10.


What is the financial health of ICHOR HOLDINGS LTD (ICHR) stock?

The financial health rating of ICHOR HOLDINGS LTD (ICHR) is 4 / 10.